Introduction
Crohn's disease (CD) is a chronic inflammatory disorder characterized by transmural intestinal inflammation with granuloma formation, which can affect any part of the gastrointestinal (GI) tract. It involves the small bowel, most commonly the terminal ileum, in around 30% to 40% of patients (1) . The "gold standard" for the diagnosis of CD includes the presence of the following features: abdominal pain, weight loss, iron deficiency anemia, diarrhea, an elevated erythrocyte sedimentation rate (ESR), fever, elevated C-reactive protein (CRP) and typical evidence of pathological processes on conventional imaging techniques, i.e., small bowel X-ray, computerized tomography (CT) of the abdomen, endoscopy, and colonoscopy with ileoscopy.
Conventional Endoscopic Imaging
The conventional endoscopic imagingendoscopic procedures, which can be used to evaluate the entire small bowel include colonoscopy with ileal intubation and push enteroscopy with mucosal biopsies, but they are limited by the length of the small bowel (2-4). These endoscopic procedures, although very useful in the evaluation of patients with suspected CD, leave a large area of the small bowel essentially unexplored. In addition, retrograde intubation of the terminal ileum (ileocolonoscopy) is not always technically feasible. Endoscopic methods that can potentially examine the small bowel in its entirety, such as sonde enteroscopy (now abandoned) (5) or intraoperative enteroscopy (3, 4) and, recently, double-balloon enteroscopy (6) are invasive, time-consuming, and associated with a recognized risk of complications, and so have rarely been used for evaluating patients with suspected CD of the small bowel.
Radiological Imaging
Radiological imaging contrast radiographic studies, such as upper GI series with smallbowel follow-through (SBFT) and/or enteroclysis, were previously considered to represent the "gold standard" for evaluating CD of the small bowel (7) , in spite of the fact that SBFT is unable to demonstrate flat lesions and has low sensitivity for raised lesions (8) . CT enteroclysis was recently introduced as an alternative imaging method to overcome the individual deficiencies of CT (i.e., no distention of the small bowel) and conventional enteroclysis (i.e., no extra-luminal information) and to combine the advantages of both in one technique. This method has been described as highly accurate in depicting mucosal abnormalities and extra-intestinal complications in patients with CD (9) . Magnetic resonance (MR) enteroclysis is a new technique that results in an excellent demonstration of the anatomy of the small bowel. It can also accurately assess luminal narrowing and extramural manifestations or complications of the disease. Imaging features, including the presence of deep ulcers, extensive wall thickening and mesenteric lymph nodes exhibiting marked gadolinium enhancement, correlate strongly with disease activity. Although the clinical utility of MR enteroclysis in CD has been widely recognized, its routine application is currently limited to academic centers (10).
• SBFT is the former "gold standard" imaging technique for evaluating the small bowel but it can not demonstrate flat lesions and has low sensitivity for raised lesions.
• CT enteroclysis accurately reveals mucosal abnormalities and extra-intestinal complications in CD but with limited sensitivity and relatively high radiation exposure.
• MR enteroclysis provides excellent demonstration of small bowel anatomy and can accurately assess luminal narrowing and extramural manifestations/complications of CD but it not always available and is relatively expensive.
Intraoperative Endoscopy
Another approach to small bowel imaging is examination of the entire small bowel by intraoperative endoscopy. The limitations of this option are the drawbacks inherently associated with exploratory laparotomy and with general anesthesia (11) .
Intraoperative endoscopy exposes small bowel pathology but it is invasive surgery that should be the last resort for acquiring information.
Capsule Endoscopy
In this methodology, the capsule propels through the entire system by means of peristalsis and collects color images of the GI tract starting at the esophagus. These data are transmitted and stored in a recorder, and finally processed in a workstation. The authors' experience (12, 13) has been with a capsule that measures 11 mm x 26 mm, weighs 3.7 g and contains four light-emitting diodes, a lens, a color camera chip, two batteries, a radio frequency transmitter, and an antenna (Fig. 1) . The camera uses a complementary metal oxide semiconductor (CMOS) chip, which requires less power than the charged coupled device (CCD) chips currently found in video endoscopes. It transmits continuous images at 2 frames per second; permitting the acquisition of more than 50,000 images during the 6-to 8-hour procedure, as it passes through the GI tract. Video images are transmitted from the capsule, using UHF-band radio telemetry, to sensor arrays taped to the patient's abdomen and stored on a portable solid-state recorder worn around the patient's waist. The recording allows physicians to locate lesions in the small intestine, as well as calculate gastric emptying time and small bowel transit time. The CE Procedure CE is a painless, noninvasive, diagnostic outpatient procedure. The patient fasts overnight and, on the morning of the procedure, swallows the capsule with a small amount of water. A trained nurse can instruct the patient and perform the procedure. Some physicians use an 
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oral purging solution and/or prokinetic drug prior to the swallowing of the capsule. The duration of the procedure is approximately 8 hours. It is mbulatory and the patient is free to continue ation cost is still a limitation since it is enerally not funded by most health insurance t evident CD ), but retention rates of 4-6% are reported in lished CD (14) . 
The Procedure's Limitations
Despite the expected life span of ~8 hours, the capsule battery may run out before the entire small bowel is visualized, particularly in cases of delayed small-bowel transit time. A critical region of interest may remain unevaluated, as in the terminal ileum in CD. Some lesions may be missed since the capsule direction and passage velocity are not controllable. Image quality is sometimes inferior to the quality of flexible video endoscopy, since the lesions cannot be washed or re-examined. The camera may be obscured by residual debris, such as bile, food, contrast barium or feces. The capsule's inability to perform biopsies limits histopathological correlation and diagnostic accuracy. Capsule examin g plans.
Complications and Safety
The capsule may be retained in the GI tract and may require endoscopic or surgical removal. Pathologies that may cause retention include benign strictures or adhesions, Crohn's strictures, and lesions (e.g., carcinoid tumor or adenomas) (14) . Retention rarely occurs at Zenker's or Meckel's diverticula (15, 16) . The overall incidence of capsule retention is low (0.1%-5%), and most of the cases are due to CD-related strictures (14) . Capsule retention occurs in <1% of patients withou (17 patients with estab Contraindications CE is contraindicated in pregnancy, in patients with known or suspected small bowel stricture, previous major abdominal surgery, dysphagia, or with implanted cardiac pacemakers, although Payeras et al. recently reported that patients with an implanted pacemaker underwent CE studies without any electrical interferences (18) . Endoscopic delivery of the capsule in patients with dysphagia, anatomical abnormality, or gastroparesis has been reported as safe and effective (19) in pediatric patients as well. A biodegradable capsule (20) , which has now become available, can be used for pretesting, in order to exclude significant luminal narrowing. This capsule may be retained in the stomach due to gastroparesis and delayed gastric emptying, a problem which may be overcome by the use of prokinetic agents. Clinical problems, such as difficulty or inability to swallow the capsule or inc m 6% of cases.
Initial Experience with CE S of CE in diagnosing CD.
The initial report by Fireman et al. (21) reported a 71% yield in diagnosing small-bowel CD: 12 of 17 patients with a normal small bowel series and colonoscopy but with h consistent with CD.
Eliakim et al. (22) studied 20 patients with suspected CD in whom the diagnosis was suspected based on abdominal pain (95%), diarrhea (75%), and weight loss (65%). Lesions that were felt to be medically significant or explained the patient's reason for referral were found in 14 of 20 patients and they included ulcers and erosions (36%), erythema (2 a and nodular lymphoid hyperplasia (5.6%).
Herrerias et al. (23) studied 21 patients with suspected CD, all of whom had diarrhea and abdominal pain. Approximately half of them also had weight loss, anemia, or leukocytosis, and approximately one-third had either fever or an elevated CRP level. Colonoscopy and small bowel series had been unremarkable in all cases. Findings compatible with CD were identified by CE in 9 patients: these included aphthae, linear or irregular ulcers, and mucosal fissures. Based on this physical evidence of disease, the patients were started on standard th they were all in clinical remission 3 months later.
Ge et al. (24) evaluated 20 patients with suspected CD who had a normal small-bowel series and colonoscopy. Inflammatory lesions were identified by CE in 13 of them and were described as mucosal erosions (n = 2), aphthous ulcers (n = 5), nodular mucosa (n = 1), large ulcers (n = 2), and ulcerated stenoses (n = 3), mostly located in the distal jejunum and ileum. These patients w
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Capsule Endoscopy -REVIEW g/d) and short-term steroids, with improvement in 11 of the 13.
Arguelles-Arias et al. (25) reported CE findings in 12 pediatric patients with suspected CD. They all had abdominal pain, weight loss, and fever, and 6 of them had diarrhea. Colonoscopy, esophagogastroduodenoscopy, and small-bowel series CE revealed abnormalities in 7 of these 12 patients: there were ulcerations in 4 and aphthous ulcerations in 3. The lesions were jejunal/ileal in 5 patients and purely ileal in 2. (35) compared CE to small bowel series and CT enterography in patients with suspected CD. Thirty-five consecutive patients with abdominal pain (89%), diarrhea (63%), or significant weight loss (45%) underwent small-bowel series followed by CE and CT enterography if a stricture was ruled out. Diagnostic findings were identified in 27 of these 35 (77%) patients: they included erosions (36%), aphthous ulcerations (22%), erythema (22%), and nodular lymphoid hyperplasia (20%). The diagnostic yield of SBFT was 23% and that of CT enterography was 20%.
et al. (36) compared CE findings to those of small-bowel series in 42 patients with established small-intestinal CD who had symptomatically active disease. Every patient underwent small bowel series, followed by CE if stricture was ruled out. Twelve patients (28%) were excluded from capsule ingestion due to obstructive findings on small-bowel series. In addition, we want to be able to pinpoint drug delivery sites in special GI diseases, such as CD. The problem here is that it would have to be done daily over a long period of time and that would be time consuming and costly. Although a pre-programmed non-viewing (i.e., no camera) capsule for drug delivery would be much cheaper, the ability to check on the healing process of the lo capsules would make this treatment efficient and cost-effective.
Small-bowel motility (and, for that matter, stomach and large bowel motility) is another area where the CE can help the clinician. The motility application in the small bowel may open a window to medical entities, such as irritable bowel syndrome, and lead to an understanding of a syndrome so ubiquitous in the western world. Fin c lymphoma and o mucosa.
Looking Ahead CE has far exceeded our early expectations by providing us with a tool to establish the correct obscure GI bleeding, CD, polyposis syndrome and others. As mentioned earlier, CE was shown to be superior to other imaging modalities, such as small bowel follow-through X-ray, colonoscopy with ileosc e diagnosing small bowel pathologies.
Gastroenterologists would obviously prefer the convenience of a single capsule that can give the entire view from the oral cavity to the anal canal in one ''shot'', but because of anatomic and physiologic differences in the GI tract, it may not be possible to use the same capsule and so we would need a different one for each organ. In addition to the original capsule, there e will soon be commercially available.
The ideal CE should be capable of performing a biopsy or carrying out an online analysis (an "optical" biopsy) and ''stop'' bleeding by an adrenaline injection, a heat probe, argon plasma coagulation, etc. The CE might even be used in the recently implemented endoscopic ultrasonography (EUS), which, for the first time, allows observation beyond the mucosal tissue. The ultimate capsule would include special detectors for white blood cells, and it would check oncological markers (e.g., CEA, CA 19-9), perform serology tests (e.g., anti-endomysial, IgE), and measure various cytokines, pH, temperature and pressure as well as deliver drugs. The capsule's motility feature in the small bowel may open a window to study the pathophysiology of relatively elusive medical entities, such as irritable bowel syndrome. The optimal capsule needs to contain an automatic computerized system for automatic detection of pathologies, such as that present in H drawback of time-consuming viewing.
We envision a system in which endoscopists will be able to ''control and steer'' the CE, as they are able to do in standard endoscopy. This would mean being able to maintain the capsule steady in a selected area and hold the view in order to have more time to examine the opposite wall of the bowel. Future gastroenterologists will have a variety of CEs from which to choose, according to the purpose of the evaluation, i.e., diagnostic and/or therapeutic. Just as the idea of a swallowed capsule's taking images as it
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reason to believe that the ultimate CE will become a reality and not in the far distant future.
In Conclusion
It can be said that the invention of CE marked the dawning of a new age of diagnostic imaging and opened up the "final frontier" of endoscopy. CE is a more sensitive examination than traditional radiography, although the specificity and positive predictive values remain to be established. CE has been proven as being an effective tool in the diagnosis and follow-up of patients with CD. Refinement of the technology by prospective comparative studies with adequate control groups and predefined clinical endpoints can be expected to establish CE as invaluable in the diagnosis and treatment of CD.
